Newsbenzinga
Niagen Bioscience Launches NAD Pharmaceuticals, Its Wholly Owned Subsidiary Focused On Developing Therapies For Accelerated Aging And Rare Genetic Diseases
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…